Oncology Bonanza As Japan Lists New Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan has added a total of 22 drug active ingredients to the national health insurance reimbursement tariff, including several novel products for cancer indications that will see their first launches worldwide.